In the Breast Centre, we recruit to and run a number of breast cancer clinical trials. This varies from observational to interventional randomised controlled trials.
All the studies have different eligibility criteria and we screen our patients accordingly. We try to approach all patients who may be eligible either in clinic or by post, but if you see something that you believe may be appropriate for you then please don’t hesitate to give us a call.
Grace Uruski also consents patients for the Wales Cancer Bank, a biobank which collects tissue and blood samples from patients in Wales to be used for worldwide research.
All our studies have been vigorously assessed by international /national ethics departments, have full approval from Research and Development, and are adopted by the National Institute of Health Research (NIHR) portfolio of studies.
NOSTRA
This is a study for patients who have HER2-positive, oestrogen receptor (ER) negative, early-stage invasive breast cancer. It is looking as to whether cancer cells are still present after neoadjuvant (pre-surgery)treatment with chemotherapy. It requires patients to consent to extra tumour bed biopsies at the end of their chemotherapy.
Grace Uruski, Wales Cancer Bank Research Nurse
Sarah Scourfield, Senior Research Officer